Recruiting
Phase 1
Phase 2

CP-383

Sponsor:

Tasca Therapeutics

Code:

NCT07030257

Conditions

Solid Tumor Malignancies

Colorectal Carcinoma

Small Cell Lung Cancer ( SCLC )

Head and Neck (HNSCC)

Bladder Cancer

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Interventions

CP-383

Study Details

Eligibility Criteria

Study Design

Interventions and Outcome Measures

Central Contacts and Locations

More Information

Trial information was received from ClinicalTrials.gov and was last updated on 2025-12-04. This information was provided to ClinicalTrials.gov by Tasca Therapeutics on 2025-10-29.